Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-23-000113

Principal Accounting Officer sold 1,232 shares at $26.26 ($32,352)

  • Principal Accounting Officer acquired 4,150 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Washburn Theodore James Jr. · Principal Accounting Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-08-01 Exercise or conversion : show line 1 in the form 10b5-1 +4,150 6,891 D
2023-08-01 Sale : show line 2 in the form 10b5-1 −1,232 $26.26 $32,352 5,659 D
Open-market sales · 1,232 sh · avg $26.26 · $32,352

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-08-01 Exercise or conversion : show line 3 in the form 10b5-1 Restricted stock units −4,150 0 D
Loading xslF345X05/wk-form4_1691006558.xml…